Literature DB >> 20519754

Surgical management of primary non-small-cell carcinoma of lung with synchronous solitary brain metastasis: local experience.

C K Lo1, C H Yu, C C Ma, K M Ko, Samuel C L Leung.   

Abstract

OBJECTIVE: To report the surgical experience in the management of patients with synchronous primary lung cancer and solitary brain metastasis.
DESIGN: Retrospective cohort study.
SETTING: Regional hospital, Hong Kong. PATIENTS: Seventeen patients with synchronous primary lung cancer and solitary brain metastasis were treated by pulmonary resection and neurosurgical intervention between 1994 and 2007.
RESULTS: Median patient survival was 52 months (95% confidence interval, 9-95 months) and the 5-year survival was 27%. The univariate analysis yielded no significant prognostic factor. Four out of six patients who had lymph node metastases developed tumour recurrence.
CONCLUSION: In view of encouraging survival results, aggressive therapy including pulmonary resection and neurosurgical intervention should be recommended for patients with synchronous presentation with primary lung cancer and solitary brain metastasis.

Entities:  

Mesh:

Year:  2010        PMID: 20519754

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  9 in total

1.  Brevican, neurocan, tenascin-C and versican are mainly responsible for the invasiveness of low-grade astrocytoma.

Authors:  Imre Varga; Gábor Hutóczki; Csaba D Szemcsák; Gábor Zahuczky; Judit Tóth; Zsolt Adamecz; Annamária Kenyeres; László Bognár; Zoltán Hanzély; Almos Klekner
Journal:  Pathol Oncol Res       Date:  2011-10-14       Impact factor: 3.201

Review 2.  Lung cancer surgery: an up to date.

Authors:  Nikolaos Baltayiannis; Michail Chandrinos; Dimitrios Anagnostopoulos; Paul Zarogoulidis; Kosmas Tsakiridis; Andreas Mpakas; Nikolaos Machairiotis; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Nikolaos Courcoutsakis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2013-09       Impact factor: 2.895

3.  Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survival.

Authors:  Phillip J Gray; Raymond H Mak; Beow Y Yeap; Sarah K Cryer; Nancy E Pinnell; Laura W Christianson; David J Sher; Nils D Arvold; Elizabeth H Baldini; Aileen B Chen; David E Kozono; Scott J Swanson; David M Jackman; Brian M Alexander
Journal:  Lung Cancer       Date:  2014-06-06       Impact factor: 5.705

4.  Long-term survival without surgery in NSCLC patients with synchronous brain oligometastasis: systemic chemotherapy revisited.

Authors:  Jun Sato; Hidehito Horinouchi; Yasushi Goto; Shintaro Kanda; Yutaka Fujiwara; Hiroshi Nokihara; Noboru Yamamoto; Yuichiro Ohe
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

5.  Improved Survival With Surgical Treatment of Primary Lung Lesions in Non-Small Cell Lung Cancer With Brain Metastases: A Propensity-Matched Analysis of Surveillance, Epidemiology, and End Results Database.

Authors:  Qing Wang; Jing Li; Xiaohua Liang; Qiong Zhan
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

6.  Treatment of brain metastasis from lung cancer.

Authors:  Alexander Chi; Ritsuko Komaki
Journal:  Cancers (Basel)       Date:  2010-12-15       Impact factor: 6.639

Review 7.  [Advances in diagnosis and treatment of brain metastases from the primary lung cancer].

Authors:  Yi Liu; Jun Chen
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2013-07

8.  [Surgical treatment for non-small cell lung cancer patients with synchronous solitary brain metastasis].

Authors:  Hao Bai; Baohui Han
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2013-12

9.  Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT).

Authors:  John Nikitas; Michael Roach; Cliff Robinson; Jeffrey Bradley; Jiayi Huang; Stephanie Perkins; Christina Tsien; Christopher Abraham
Journal:  Clin Transl Radiat Oncol       Date:  2019-12-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.